A detailed history of Israel Englander (Millennium Management LLC) transactions in Nkarta, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 66,100 shares of NKTX stock, worth $165,250. This represents 0.0% of its overall portfolio holdings.

Number of Shares
66,100
Previous 281,677 76.53%
Holding current value
$165,250
Previous $1.66 Million 82.09%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.52 - $8.0 $207,703 - $367,616
-45,952 Reduced 16.31%
235,725 $1.07 Million
Q2 2024

Aug 14, 2024

BUY
$5.27 - $10.82 $1.29 Million - $2.65 Million
245,251 Added 673.29%
281,677 $1.66 Million
Q1 2024

May 15, 2024

SELL
$5.59 - $15.71 $388,186 - $1.09 Million
-69,443 Reduced 65.59%
36,426 $393,000
Q4 2023

Feb 14, 2024

BUY
$1.31 - $6.6 $120,423 - $606,711
91,926 Added 659.3%
105,869 $698,000
Q2 2023

Aug 14, 2023

SELL
$2.19 - $5.17 $127 - $299
-58 Reduced 0.41%
13,943 $30,000
Q1 2023

May 15, 2023

SELL
$3.37 - $6.3 $538,108 - $1.01 Million
-159,676 Reduced 91.94%
14,001 $50,000
Q4 2022

Feb 14, 2023

BUY
$5.14 - $14.35 $657,673 - $1.84 Million
127,952 Added 279.83%
173,677 $1.04 Million
Q3 2022

Nov 14, 2022

BUY
$12.27 - $18.39 $561,045 - $840,882
45,725 New
45,725 $602,000

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $122M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.